consolidated financial statements fiscal year ended december otsuka holdings co ltd financial information basis preparation consolidated financial statements consolidated financial statements otsuka holdings company limited hereinafter referred company prepared accordance international financial reporting standards hereinafter referred ifrs pursuant provision article ordinance terminology forms preparation methods consolidated financial statements ordinance ministry finance hereinafter referred ordinance consolidated financial statements audit certification accordance provision article paragraph financial instruments exchange act consolidated financial statements fiscal year ended december audited deloitte touche tohmatsu llc special effort ensure appropriateness consolidated financial statements others development system preparing consolidated financial statements appropriately accordance ifrs company making special effort ensure appropriateness consolidated financial statements others developing system preparing consolidated financial statements others appropriately accordance ifrs details follows order develop system ensures proper understanding contents accounting standards etc adequate response changes accounting standards etc others company joined financial accounting standards foundation regularly provides internal training subscribes professional journals published japanese institute certified public accountants attends seminars hosted financial accounting standards foundation auditing firms etc makes efforts regard application ifrs company keeps accounting standards obtaining press releases standards published international accounting standards board addition company developed groups accounting policies accounting guidelines accordance ifrs practices accounting procedures based policies guidelines prepare appropriate consolidate financial statements accordance ifrs consolidated financial statements consolidated financial statements consolidated statements financial position millions yen fy fy note december december assets current assets cash cash equivalents trade receivables inventories income taxes receivable financial assets current assets subtotal assets held sale total current assets noncurrent assets property plant equipment goodwill intangible assets investments associates financial assets deferred tax assets noncurrent assets total noncurrent assets total assets millions yen fy fy note december december liabilities equity liabilities current liabilities trade payables bonds borrowings lease liabilities financial liabilities income taxes payable contract liabilities current liabilities total current liabilities noncurrent liabilities bonds borrowings lease liabilities financial liabilities net defined benefit liabilities provisions contract liabilities deferred tax liabilities noncurrent liabilities total noncurrent liabilities total liabilities equity equity attributable owners company share capital capital surplus treasury shares retained earnings components equity total equity attributable owners company noncontrolling interests total equity total liabilities equity ii consolidated statements income millions yen fy fy note january january december december revenue cost sales gross profit selling general administrative expenses share profit associates research development expenses impairment losses income expenses operating profit finance income finance costs profit taxes income tax expenses profit year attributable owners company noncontrolling interests earnings per share basic earnings per share yen diluted earnings per share yen iii consolidated statements comprehensive income millions yen fy fy note january january december december profit year comprehensive income components reclassified profit loss remeasurements defined benefit plans financial assets measured fair value comprehensive income share comprehensive income associates subtotal components may reclassified profit loss foreign currency translation reserve cash flow hedges share comprehensive income associates subtotal total comprehensive income comprehensive income attributable owners company noncontrolling interests comprehensive income iv consolidated statements changes equity fy january december millions yen equity attributable owners company components equity financial assets remeasure measured capital treasury retained ments fair value note share capital surplus shares earnings defined benefit plans comprehen sive income balance january changes accounting policies restated balance profit year comprehensive income comprehensive income purchase treasury shares dividends sharebased payment transactions changes ownership interests subsidiaries result loss control disposal subsidiaries transfer components equity retained earnings total transactions owners etc balance december equity attributable owners company components equity foreign non currency cash flow note total total controlling total equity translation hedges interests reserve balance january changes accounting policies restated balance profit year comprehensive income comprehensive income purchase treasury shares dividends sharebased payment transactions changes ownership interests subsidiaries result loss control disposal subsidiaries transfer components equity retained earnings total transactions owners etc balance december fy january december millions yen equity attributable owners company components equity financial assets remeasure measured capital treasury retained ments fair value note share capital surplus shares earnings defined benefit plans comprehen sive income balance january changes accounting policies restated balance profit year comprehensive income comprehensive income purchase treasury shares dividends sharebased payment transactions exercise stock options changes ownership interests subsidiaries result loss control transfer components equity retained earnings total transactions owners etc balance december equity attributable owners company components equity foreign non currency cash flow note total total controlling total equity translation hedges interests reserve balance january changes accounting policies restated balance profit year comprehensive income comprehensive income purchase treasury shares dividends sharebased payment transactions exercise stock options changes ownership interests subsidiaries result loss control transfer components equity retained earnings total transactions owners etc balance december v consolidated statements cash flows millions yen fy fy note january january december december cash flows operating activities profit taxes depreciation amortization expenses impairment losses reversals impairment losses share loss profit associates finance income finance costs decrease increase inventories decrease increase trade receivables increase decrease trade payables others subtotal interest dividends received interest paid income taxes paid net cash flows used operating activities cash flows investing activities proceeds sales property plant equipment payments acquisition property plant equipment payments acquisition intangible assets proceeds sales redemption investments payments acquisition investments payments acquisition subsidiaries decrease increase time deposits others net cash flows used investing activities cash flows financing activities proceeds issuance bonds purchase treasury shares increase decrease current borrowings proceeds noncurrent borrowings repayments noncurrent borrowings repayments lease liabilities dividends paid others net cash flows used financing activities increase decrease cash cash equivalents cash cash equivalents beginning period effect exchange rate changes cash cash equivalents cash cash equivalents end period notes consolidated financial statements reporting entity otsuka holdings company limited hereinafter referred company company incorporated japan addresses registered head office principal business offices disclosed companys website url httpswwwotsukacomen consolidated financial statements company prepared end fiscal year december comprise company subsidiaries hereinafter referred group interests associates details businesses principal business activities group provided note operating segments basis preparation compliance ifrs pursuant provision article ordinance consolidated financial statements consolidated financial statements company prepared compliance ifrs since company qualifies specified company designated international accounting standards prescribed article ordinance companys consolidated financial statements fiscal year ended december approved march tatsuo higuchi president representative director ceo yuko makino executive director cfo basis measurement consolidated financial statements prepared historical cost basis except financial instruments etc measured fair value functional currency presentation currency consolidated financial statements presented japanese yen companys functional currency figures rounded nearest million yen changes accounting policies group adopted following standards current fiscal year ifrs description newly issued standards interpretations amendments ifrs leases amendment concerning accounting treatment leases current fiscal year group adopted ifrs leases issued january hereinafter referred ifrs adoption ifrs rightofuse assets lease liabilities recognized date initial application ifrs january leases previously classified operating leases applying ias leases hereinafter referred ias addition operating lease payments expensed incurred applying ias recorded depreciation rightofuse assets interest costs lease liabilities consolidated statement income current fiscal year reclassified reduction cash flows operating activities reduction cash flows financing activities consolidated statement cash flows details accounting policy leases provided note significant accounting policies leases accordance transition requirement ifrs group retrospectively adopted ifrs recognized cumulative effect initially applying ifrs adjustment opening balance retained earnings current fiscal year transitioning ifrs group chooses practical expedient detailed ifrs paragraph c whether contract contains lease continuously utilizes result assessment applying ias ifric determining whether arrangement contains lease lease liabilities measured present value lease payments paid commence date discounted using lessees incremental borrowing rate date initial application weighted average lessees incremental borrowing rate applied lease liabilities recognized consolidated statement financial position date initial application rightofuse assets initially measured initial measurement lease liabilities adjusted amount prepaid accrued lease payments result compared application previous accounting standard beginning current fiscal year rightofuse assets increased million property plant equipment consolidated statement financial position retained earnings decreased million following reconciliation operating lease contracts disclosed applying ias end previous fiscal year lease liabilities recognized consolidated statement financial position date initial application millions yen amount operating lease contracts disclosed december operating lease contracts discounted using incremental borrowing rate january finance lease contracts disclosed december lease contracts accounted shortterm lease expenses cancellable operating lease contracts others lease liabilities january application ifrs group applies following practical expedients detailed ifrs paragraph c single discount rate applied portfolio leases reasonably similar characteristics leases lease term ends within months date initial application accounted way shortterm leases initial direct costs excluded measurement rightofuse asset date initial application hindsight used determining lease term contract containing options extend terminate lease changes presentation consolidated statements financial position group adopted ifrs current fiscal year line application lease liabilities included financial liabilities previous fiscal year separately presented current fiscal year due increased materiality amount reflect change presentation consolidated financial statements previous fiscal year reclassified accordingly result million previously presented financial liabilities current liabilities million previously presented financial liabilities noncurrent liabilities reclassified lease liabilities current liabilities lease liabilities non current liabilities respectively consolidated statements income purpose providing useful clearer information future cash flow projection others decided impairment losses inprocess research development included research development expenses impairment losses included selling general administrative expenses previous fiscal year separately presented aggregate impairment losses current fiscal year reflect change presentation consolidated financial statements previous fiscal year reclassified accordingly result million previously included research development expenses million previously included selling general administrative expenses reclassified million impairment losses consolidated statements cash flows group adopted ifrs current fiscal year line application repayments lease liabilities included cash flows financing activities previous fiscal year separately presented current fiscal year due increased materiality amount reflect change presentation consolidated financial statements previous fiscal year reclassified accordingly result million previously presented cash flows financing activities reclassified repayments lease liabilities cash flows financing activities new standards yet adopted among standards interpretations newly issued amended date approval described note basis preparation new amended standards interpretations early adopted group december impact adoption standards interpretations provided expected insignificant significant accounting policies basis consolidation subsidiaries subsidiaries entities controlled group group controls investee group power investee exposed rights variable returns arising groups involvement investee ability affect returns power investee financial statements subsidiaries included consolidated financial statements date group gains control date control lost accounting policies applied subsidiary differ applied group adjustments made subsidiarys financial statements needed balances payables receivables internal transactions within group companies well unrealized gains losses arising internal transactions offset preparing consolidated financial statements ownership interest subsidiary partially disposed transaction accounted equity transaction group retains control subsidiary difference amount adjustment noncontrolling interests fair value consideration paid received recognized directly equity attributable owners company group loses control subsidiary gains losses derived loss recognized profit loss ii associates associates entities group significant influence terms financial operating policies group control jointly control group presumed significant influence another entity holds least less voting rights entity investments associates recognized cost time acquisition subsequently accounted using equity method goodwill recognized acquisition included investments associates goodwill separately recognized tested impairment separately instead entire amount investments associates tested impairment single asset whenever objective evidence indicates investments associates may impaired accounting policies applied associate differ applied group adjustments made associates financial statements needed group retained interests losing significant influence interests measured fair value difference fair value carrying amount investment date equity method discontinued recognized profit loss business combinations business combinations accounted using acquisition method goodwill measured excess aggregate consideration transferred amount non controlling interests acquiree acquisitiondate fair value acquirers previously held equity interest acquiree net acquisitiondate amounts identifiable assets acquired liabilities assumed case identifiable net asset exceeds aggregate consideration others excess immediately recognized profit loss consideration transferred calculated sum acquisitiondate fair values assets transferred acquirer liabilities incurred acquirer former owners acquiree equity interests issued acquirer consideration transferred includes assets liabilities resulting contingent consideration arrangement amount noncontrolling interests acquiree measured business combination either fair value present ownership instruments proportionate share recognized amounts acquirees identifiable net assets identifiable assets acquired liabilities assumed acquisition date measured fair values acquisition date except limited exceptions based requirements ifrs business combinations transaction costs incurred relation business combinations recognized expenses incurred initial accounting business combinations incomplete end fiscal year business combinations occur group reports provisional amounts items accounting incomplete provisional amounts recognized acquisition date retrospectively adjusted reflect new information obtained measurement period facts circumstances existed acquisition date known acquisition date would affected measurement amounts recognized additional assets liabilities recognized new information known resulted additional recognition assets liabilities measurement period exceed one year foreign currency translation foreign currency transactions foreign currency transactions translated respective functional currencies group companies exchange rates transaction dates exchange rates close actual rate transaction dates foreign currency monetary assets liabilities translated functional currency closing rate foreign currency monetary assets liabilities measured fair value translated functional currency using exchange rate date measurement translation differences arising translations settlements recognized profit loss provided however translation differences arising financial assets measured comprehensive income well cash flow hedges recognized comprehensive income ii foreign operations assets liabilities foreign operations translated japanese yen closing rate revenues expenses foreign operations translated japanese yen average exchange rate reporting period translation differences arising translation financial statements foreign operations recognized comprehensive income foreign currency translation reserve recognized profit loss periods foreign operations disposed financial instruments financial assets initial recognition measurement trade receivables initially recognized date incurred financial assets initially recognized contract date group becomes party contractual provisions financial instruments initial recognition financial assets except measured fair value profit loss measured fair value plus directly attributable transaction costs transaction costs financial assets measured profit loss recognized profit loss initial recognition financial assets classified financial assets measured amortized cost b debt instruments measured fair value comprehensive income c equity instruments measured fair value comprehensive income financial assets measured fair value profit loss financial assets measured amortized cost financial assets classified financial assets measured amortized cost following conditions met financial asset held within business model whose objective hold financial assets order collect contractual cash flows contractual terms financial asset give rise specified dates cash flows solely payments principal interest principal amount outstanding b debt instruments measured fair value comprehensive income financial assets classified debt instruments measured fair value comprehensive income following conditions met financial asset held within business model whose objective achieved collecting contractual cash flows selling financial assets contractual terms financial asset give rise specified dates cash flows solely payments principal interest principal amount outstanding c equity instruments measured fair value comprehensive income investments equity instruments group chosen irrevocable option present subsequent changes fair value investments neither held trading contingent consideration recognized acquirer business combination ifrs business combinations applies comprehensive income group classifies investments equity instruments measured fair value comprehensive income financial assets measured fair value profit loss financial assets except financial assets measured amortized cost debt instruments measured fair value comprehensive income equity instruments measured fair value comprehensive income stated classified financial assets measured fair value profit loss ii subsequent measurement initial recognition financial assets measured according classification follows financial assets measured amortized cost financial assets measured amortized cost measured amortized cost using effective interest method amortization using effective interest method gains losses arising case derecognition recognized profit loss b equity instruments measured fair value comprehensive income equity instruments measured fair value comprehensive income measured fair value changes fair value recognized comprehensive income financial assets derecognized accumulated comprehensive income transferred retained earnings meanwhile dividends financial assets recognized profit loss c financial assets measured fair value profit loss financial assets measured fair value profit loss measured fair value changes fair value recognized profit loss iii impairment respect impairment financial assets measured amortized cost group recognizes allowance expected credit losses financial assets end fiscal year group evaluates whether credit risk financial instruments increased significantly since initial recognition credit risk financial instrument increased significantly since initial recognition allowance instrument measured amount equal month expected credit losses credit risk financial instrument increased significantly since initial recognition allowance financial instrument measured amount equal lifetime expected credit losses group considers ruleofthumb significant increase credit risk payments made days passed since contractual due date assessment whether credit risk increased significantly takes account relevant current information reasonably available group well historic information credit risk financial asset considered low end fiscal year group determines credit risk financial asset increased significantly since initial recognition however regards trade receivables etc contain significant financing component allowance always measured amount equal lifetime expected credit losses regardless whether significant increase credit risk since initial recognition expected credit losses financial instrument measured using methodology reflects following unbiased probabilityweighted loss determined evaluating range possible outcomes time value money reasonable supportable information available without undue cost effort reporting date past events current conditions forecasts future economic conditions changes measurements recognized profit loss amount expected credit losses reversal required adjust loss allowance end fiscal year amount required recognized recognized impairment gains impairment losses iv derecognition group derecognizes financial assets contractual rights cash flows financial assets expire group transfers substantially risks rewards ownership financial assets ii financial liabilities initial recognition measurement bonds borrowings initially recognized date issued incurred financial liabilities initially recognized contract date group becomes party contractual provisions financial instruments initial recognition financial liabilities classified financial liabilities measured amortized cost b financial liabilities measured fair value profit loss initial recognition financial liabilities measured amortized cost measured fair value net transaction costs directly attributable financial liability transaction costs financial liabilities measured fair value profit loss recognized profit loss ii subsequent measurement initial recognition financial liabilities measured according classification follows financial liabilities measured amortized cost financial liabilities measured amortized cost measured amortized cost using effective interest method amortization using effective interest method gains losses arising case derecognition recognized profit loss b financial liabilities measured fair value profit loss financial liabilities measured fair value profit loss measured fair value changes fair value recognized profit loss iii derecognition group derecognizes financial liability financial liability extinguished obligations specified contract discharged cancelled expired iii offsetting financial assets financial liabilities financial assets financial liabilities offset net amount presented group currently legally enforceable right set recognized amount intends either settle net basis realize assets settle liabilities simultaneously iv derivatives hedge accounting derivatives initially recognized fair value initial recognition derivatives continue measured fair value group utilizes forward foreign exchange contracts currency swap agreements currency option transactions interest rate swap agreements derivatives hedge foreign currency risk interest rate risk inception hedging relationship group formally designates documents hedging relationship risk management objective strategy undertaking hedge documentation includes identification hedging instrument hedged item nature risk hedged methods assessing whether hedging relationship meets hedge effectiveness requirements group assesses whether hedging relationship meets hedge effectiveness requirements inception ongoing basis ongoing assessments performed reporting date upon significant change circumstances affecting hedge effectiveness requirements whichever comes first group applies hedge accounting cash flow hedges meet criteria hedge accounting hedges accounted follows portions gain loss hedging instrument determined effective hedges recognized comprehensive income remaining ineffective portions recognized profit loss amounts associated hedging instruments recognized comprehensive income reclassified profit loss hedged transactions affect profit loss however cases hedged forecast transaction subsequently results recognition nonfinancial asset liability amount recognized comprehensive income accounted adjustment initial carrying amount nonfinancial asset liability hedging relationship ceases meet qualifying criteria hedging instrument expires sold terminated exercised application hedge accounting discontinued prospectively forecast transactions firm commitments longer expected occur related cumulative gains losses recognized equity comprehensive income reclassified profit loss group undertake fair value hedges hedges net investment foreign operations cash cash equivalents cash cash equivalents consist cash hand demand deposits shortterm investments repayment terms three months less date acquisition readily convertible cash subject insignificant risk changes value inventories inventories measured lower cost net realizable value net realizable value estimated selling price ordinary course business less estimated costs completion estimated costs necessary make sale cost inventories determined mainly using weighted average cost formula cost inventories comprises costs purchase costs conversion costs incurred bringing inventories present location condition property plant equipment cost model applied measurement property plant equipment property plant equipment carried cost less accumulated depreciation accumulated impairment losses cost property plant equipment includes cost directly incidental acquisition assets initial estimated costs dismantling removing assets restoration costs depreciation expense assets except land construction progress recognized mainly straightline method respective estimated useful lives estimated useful lives major asset items follows buildings structures years machinery vehicles years tools furniture fixtures years estimated useful lives residual values depreciation methods assets reviewed end fiscal year changes applied prospectively change accounting estimate goodwill measurement goodwill initial recognition provided business combinations initial recognition amount recorded cost less accumulated impairment losses goodwill allocated cashgenerating units groups cashgenerating units hereinafter referred cashgenerating units expected benefit synergies business combination cashgenerating units goodwill allocated tested impairment annually whenever indication unit may impaired recoverable amount cashgenerating units less carrying amounts impairment loss recognized profit loss regard allocation impairment losses recognized association cashgenerating units first carrying amount goodwill allocated unit reduced remaining amount impairment loss allocated assets unit pro rata basis carrying amount asset unit impairment losses recognized goodwill reversal made subsequent periods intangible assets cost model applied measurement intangible assets intangible assets carried cost less accumulated amortization accumulated impairment losses separately acquired intangible assets measured cost time initial recognition intangible assets acquired business combinations measured fair value acquisition date internally generated intangible assets development expenses meet requirements capitalization recognized expense incurred amortization expense intangible asset finite useful life recognized straightline method estimated useful life estimated useful lives major intangible assets follows patents years trademarks distribution rights others years software years estimated useful lives residual values amortization methods reviewed end fiscal year changes applied prospectively change accounting estimate intangible assets indefinite useful lives consist mainly brands trademarks acquired separately business combinations included intangible assets trademarks distribution rights others intangible assets indefinite useful lives reviewed end fiscal year determine whether indefinite useful life assessment remains appropriate longer appropriate change useful life assessment indefinite finite accounted change accounting estimate inprocess research development acquired separately business combinations included intangible assets inprocess research development assets intangible assets yet available use amortized tested impairment asset inprocess research development transferred trademarks distribution rights others asset becomes available use obtaining permits approvals regulatory authorities subsequent period begins amortized straightline method estimated useful life time leases fy january december lease transactions substantially risks rewards incidental ownership transferred group classified finance leases lease transactions classified operating leases regards finance leases group initially recognizes lease assets liabilities fair value leased property lower present value minimum lease payments determined inception lease leased assets depreciated using straightline method shorter estimated useful lives lease terms lease payments apportioned finance costs repayments lease obligations finance costs allocated period lease term produce constant periodic rate interest remaining balance liability lease payments operating leases recognized expenses using straightline method lease term fy january december leases group contracted lessee rightofuse assets measured cost lease liabilities measured present value lease payments paid rightofuse assets depreciated using straightline method shorter estimated useful lives lease terms lease payments recognized upon apportionment finance costs repayments lease liabilities based interest method group recognize rightofuse assets lease liabilities leases intangible assets shortterm leases within months group recognizes lease payments relating shortterm leases either straightline basis lease term another systematic basis impairment property plant equipment intangible assets group assesses whether indication impairment end fiscal year property plant equipment intangible assets indication exists recoverable amount asset estimated possible estimate recoverable amount individual asset group estimates recoverable amount cashgenerating unit asset belongs cash generating unit smallest identifiable group assets generates cash inflows largely independent cash inflows assets groups assets intangible assets indefinite useful lives yet available use recoverable amounts estimated end fiscal year regardless whether indication impairment recoverable amount individual asset cashgenerating unit measured higher fair value less cost disposal value use value use calculated discounting estimated future cash flows present value using pretax discount rate reflects time value money risks specific asset corporate assets independently generate cash inflows indication impairment corporate assets recoverable amount cashgenerating unit corporate assets belong calculated impairment loss recognized profit loss carrying amount asset cashgenerating unit exceeds recoverable amount impairment loss recognized prior periods group assesses whether indication decrease disappearance impairment loss end fiscal year indication reversal impairment loss recoverable amounts assets cashgenerating units estimated cases recoverable amount exceeds carrying amount asset cashgenerating unit impairment loss reversed lower recoverable amount carrying amount less depreciation amortization costs would determined impairment loss recognized assets held sale assets groups assets expected recovered continuous use sale classified non current assets disposal groups held sale quite likely sold within one year available immediate sale present condition management group committed sale case noncurrent assets neither depreciated amortized measured carrying amount fair value less cost sales whichever lower postemployment benefits groups postemployment benefit plans employees include defined benefit plans defined contribution plans group uses projected unit credit method determine present value defined benefit obligations related current service cost past service cost discount rate determined based market yields high quality corporate bonds end fiscal year consistent discount period set projected period expected date benefit payment fiscal year net defined benefit liabilities assets calculated deducting fair value plan assets present value defined benefit obligations defined benefit plan surplus defined benefit asset limited asset ceiling present value future economic benefits available form reductions future contributions plan cash refunds service costs net interest net defined benefit liabilities assets recognized profit loss remeasured amount defined benefit plan recognized comprehensive income occurs immediately transferred retained earnings contributions defined contribution retirement benefits recognized expenses employees rendered service provisions provisions recognized present legal constructive obligations result past events probable outflows resources embodying economic benefits required settle obligations reliable estimates made amount obligations amount recognized provisions best estimate taking account risks uncertainties expenditure required settle present obligations reporting date time value money material amount provision measured present value expenditures expected required settle obligation treasury shares treasury shares measured acquisition cost deducted equity gain loss recognized associated purchase sale retirement treasury shares company difference carrying amount consideration received sale recognized capital surplus sharebased payments equitysettled sharebased payment plan group adopted restricted stock compensation plan accounted equitysettled share based payment plan current fiscal year stock option plan terminated due elapse applicable service period plan stock options exercised current fiscal year restricted stock compensation measured fair value grant date recognized expenses vesting periods grant date corresponding amounts increases equity fair value restricted stock compensation measured reference fair value granted shares company ii cashsettled sharebased payment plan group adopted equitylinked compensation entitlements cashsettled sharebased payment plan cashsettled sharebased payments fair value payments recognized liability changes fair value liability recognized profit loss liability settled revenue sales products sales products performance obligation judged satisfied revenue therefore recognized upon delivery products legal title physical possession significant risks rewards ownership products transferred customer upon delivery customer obtains control products products may sold rebate based upon achievement defined sales volume amount case transaction price recognized consideration promised contract less estimated rebates items rebates measured likely amount method based historical performance revenue recognized extent highly probable significant reversal occur consideration sales received primarily within one year time delivery include significant financing component ii license royalty income license income upfront milestone payments group receives based license agreements etc group third party enter development distribution right developing finished products license agreements etc contractual obligations fulfilled specific point time upfront payments recognized revenue development distribution rights granted contractual obligations fulfilled period time payments recorded contract liabilities recognized revenue period estimated contract term etc accordance method measuring progress towards complete satisfaction performance obligations related development cooperation determined contract income milestone payments received license agreements recognized revenue point conditions met avoid future reversal revenues royalty income income license agreements etc calculated based sales etc counterparties revenue recognized later point either counterpartys revenue recognition etc satisfaction performance obligations license royalty income received primarily within one year time right amount earned based contract include material financing component government grants grant income measured fair value recognized reasonable assurance group comply conditions attached grants grants received grants revenue incurred recorded revenue fiscal year expenses occurred grants assets recorded revenue regularly useful life asset unearned grant income recorded liability finance income finance costs finance income principally consists interest income dividend income gain fair value valuation foreign exchange gains interest income recognized using effective interest method income arises dividend income recognized groups right receive dividend established finance costs principally consist interest expenses loss fair value valuation foreign exchange losses income taxes income taxes consist current taxes deferred taxes taxes recognized profit loss except related business combinations items recognized directly equity comprehensive income current taxes measured amount expected tax payment expected tax refund tax authorities amount taxes computed accordance tax rates tax laws effect substantially effect end fiscal year countries group conducts business activities earns taxable profits losses deferred taxes recognized temporary differences accounting carrying amounts assets liabilities reporting date amounts tax purposes unused tax losses unused tax credits deferred tax assets liabilities recorded following temporary differences temporary differences arising goodwill temporary differences arising initial recognition assets liabilities occur transactions affect neither accounting profit taxable profit tax purposes except business combinations cases taxable temporary differences associated investments subsidiaries associates timing reversal controlled highly probable temporary differences reversed foreseeable period cases deductible temporary differences associated investments subsidiaries associates highly probable temporary differences reversed extent foreseeable deferred tax liabilities recognized principle taxable temporary differences deferred tax assets recognized deductible temporary differences extent highly probable taxable profits available deductible temporary differences could utilized carrying amount deferred tax assets reviewed every period reduced amount deferred tax assets taxable profit sufficient use part deferred tax assets unlikely earned unrecognized deferred tax assets reassessed every period recognized extent highly probable deferred tax assets realizable future taxable profit company certain domestic subsidiaries adopted consolidated taxation system current fiscal year deferred tax assets liabilities calculated accordance tax rates tax laws expected applied period assets realized liabilities settled based tax rates tax laws effect substantially effect end fiscal year deferred tax assets liabilities offset group legally enforceable right offset current tax assets current tax liabilities related income taxes levied taxation authority taxable entity earnings per share basic earnings per share calculated dividing profit loss year attributable ordinary equity holders company weighted average number ordinary shares issued period adjusted number treasury shares diluted earnings per share calculated reflecting adjustment impact diluted shares dilutive effect significant accounting estimates judgments preparing ifrscompliant consolidated financial statements management required make judgments estimates assumptions may affect application accounting policies reported amounts assets liabilities revenue expenses actual results may differ estimates estimates underlying assumptions reviewed ongoing basis effects review accounting estimates recognized accounting period review conducted future accounting periods items management made estimates judgments significant effects amounts recognized consolidated financial statements follows useful lives property plant equipment intangible assets items note significant accounting policies notes property plant equipment goodwill intangible assets impairment property plant equipment goodwill intangible assets items note significant accounting policies note impairment assets fair value measurement financial instruments note financial instruments recoverability deferred tax assets note income taxes accounting measurement provisions note provisions measurements defined benefit obligations note postemployment benefits revenue recognition item note significant accounting policies note revenue contingent liabilities note contingent liabilities operating segments overview reportable segments groups reportable segments constituent units group separate financial information available subject periodic reviews board directors order make decisions allocation business resources evaluate business performances respective segments groups holding company company directs groups strategic planning monitors group operations provides various services group companies business activities conducted groups subsidiaries associates centering healthcare business group operates activities inside outside japan relating following four reportable segments pharmaceuticals nutraceuticals consumer products others businesses group defines reportable segments follows pharmaceuticals comprises manufacturing sales prescription drugs intravenous solutions others nutraceuticals comprises manufacturing sales functional beverages etc overthecounter drugs nutritional supplements consumer products comprises manufacturing sales mineral water soft beverages food products others encompasses logistics warehousing manufacturing sales chemical products evaluation systems led displays spectroanalysis devices revenue performances reportable segment revenue performances groups reportable segment follows segment profit based operating profit intersegment revenue transfers reflect reasonable prices intersegment transfers based market value fy january december millions yen reportable segment adjustments consolidated pharma nutra consumer others total ceuticals ceuticals products revenue revenue external customers intersegment revenue transfers total segment profit items depreciation amortization expenses share profit associates impairment losses capital expenditures fy january december millions yen reportable segment adjustments consolidated pharma nutra consumer others total ceuticals ceuticals products revenue revenue external customers intersegment revenue transfers total segment profit items depreciation amortization expenses share profit associates impairment losses capital expenditures details adjustments follows segment profit details adjustments segment profit follows millions yen fy fy january january december december intersegment eliminations unallocated expenses income total unallocated expenses consist mainly costs headquarters functions company certain subsidiaries ii items depreciation amortization expenses impairment losses adjustments include depreciation amortization expenses impairment losses property plant equipment intangible assets assets associated headquarters functions company certain subsidiaries iii capital expenditures adjustments include capital expenditures relating assets associated headquarters research functions company certain subsidiaries capital expenditures represent amount increases property plant equipment goodwill intangible assets information products services revenue external customers major product service follows millions yen fy fy january january december december pharmaceuticals abilify maintena rexulti samsca clinical nutrition nutraceuticals functional beverages etc functional foods etc supplements functional beverages etc consist pocari sweat tiovita drink oronamin c fibemini os body maint etc result reviewing major product groups functional beverages etc line third medium term management plan started fy revenue os body maint etc also included fy reflect change amount fy increased million functional foods etc consist products nutrition sant sas group calorie mate products daiya foods inc etc result reviewing major product groups functional foods etc well revenue products daiya foods inc etc also included fy reflect change amount fy increased million supplements consist products pharmavite llc group equelle etc result reviewing major product groups supplements well revenue equelle etc also included fy reflect change amount fy increased million information geographical area revenue external customers millions yen fy fy january january december december japan north america others total revenue external customers classified based location customers amounts north america revenue united states fy fy million million respectively noncurrent assets millions yen fy fy december december japan north america others total noncurrent assets classified based location assets noncurrent assets include investments associates financial assets deferred tax assets net defined benefit assets goodwill included noncurrent assets classified based location investees amounts north america noncurrent assets united states fy fy million million respectively information major customers information presented revenue transactions single external customer amounts groups revenue cash cash equivalents breakdown cash cash equivalents follows millions yen fy fy december december cash cash equivalents cash deposits banks deposit terms within three months shortterm investments redeemable within three months total cash cash equivalents trade receivables breakdown trade receivables follows millions yen fy fy december december trade accounts notes receivable accounts receivable allowance credit losses total amount assets pledged collateral borrowings included trade receivables million fy million fy inventories breakdown inventories follows millions yen fy fy december december merchandise finished goods workin process raw materials supplies total inventories scheduled sold months cost inventories recognized expenses million fy million fy amount assets pledged collateral borrowings included inventories million fy million fy amount writedowns inventories recognized expense follows millions yen fy fy january january december december amount writedowns financial assets breakdown financial assets follows millions yen fy fy december december financial assets financial assets measured amortized cost time deposits loans receivable bonds others financial assets measured fair value profit loss derivative assets others financial assets measured fair value comprehensive income equity instruments total financial assets current financial assets noncurrent assets breakdown assets follows millions yen fy fy december december assets prepaid expenses net defined benefit assets others total total current assets current assets total noncurrent assets noncurrent assets assets held sale breakdown assets held sale liabilities directly associated assets held sale follows millions yen fy fy december december assets held sale property plant equipment buildings structures machinery vehicles land construction progress total major assets held sale fy idle assets pharmaceutical business nutraceutical business classified assets held sale decision sell assets sales completed fy major assets held sale fy idle assets consumer products business classified assets held sale decision sell assets assets held sale measured lower carrying amount fair value less costs sell fair value assets held sale expected sales price less cost disposal classified level hierarchy fair value hierarchy provided note financial instruments assets impairment losses million recorded fy included impairment losses consolidated statement income sales scheduled completed following fiscal year property plant equipment changes costs accumulated depreciation accumulated impairment losses property plant equipment carrying amounts follows costs millions yen buildings machinery tools furniture construction land total structures vehicles fixtures progress balance january purchase business combination disposal transfer transfer assets held sale foreign currency translation differences others balance december adjustment due application ifrs adjusted balance january purchase disposal transfer transfer assets held sale foreign currency translation differences others balance december accumulated depreciation accumulated impairment losses millions yen buildings machinery tools furniture construction land total structures vehicles fixtures progress balance january depreciation expenses impairment losses disposal transfer assets held sale foreign currency translation differences others balance december depreciation expenses impairment losses disposal transfer assets held sale foreign currency translation differences others balance december carrying amounts millions yen buildings machinery tools furniture construction land total structures vehicles fixtures progress balance january balance december balance december table amount related property plant equipment construction presented construction progress amounts related item property plant equipment include amount rightofuse assets please refer notes income expenses gain sales noncurrent assets loss sales noncurrent assets loss retirement noncurrent assets fy fy gain sales noncurrent assets loss sales noncurrent assets include gain loss sales assets held sale please refer note impairment assets details impairment losses please refer note commitments commitments related acquisition property plant equipment significant borrowing cost included costs property plant equipment assets pledged collateral carrying amounts assets pledged collateral borrowings etc included item property plant equipment follows millions yen buildings machinery tools furniture land total structures vehicles fixtures balance january balance december balance december rightofuse assets carrying amount rightofuse assets included item property plant equipment leased assets finance leases fy please refer note leases goodwill intangible assets changes costs accumulated amortization accumulated impairment losses goodwill intangible assets follows costs millions yen intangible assets trademarks goodwill inprocess distribution research software others total rights development others balance january purchase business combination disposal transfer foreign currency translation differences others balance december purchase disposal transfer foreign currency translation differences others balance december accumulated amortization accumulated impairment losses millions yen intangible assets trademarks goodwill inprocess distribution research software others total rights development others balance january amortization expenses impairment losses disposal foreign currency translation differences others balance december amortization expenses impairment losses disposal transfer foreign currency translation differences others balance december carrying amounts millions yen intangible assets goodwill inprocess trademarks research distribution software others total development rights others balance january balance december balance december amortization expenses intangible assets included cost sales selling general administrative expenses research development expenses consolidated statements income please refer note impairment assets details impairment losses please refer note commitments commitments related acquisition intangible assets borrowing cost included costs intangible assets assets pledged collateral applicable individually significant intangible assets major intangible assets recorded consolidated statements financial position rights associated research development avp rights associated nuedexta recognized line acquisition avanir pharmaceuticals inc executed carrying amounts rights associated research development avp nuedexta million million respectively fy million million respectively fy assets amortization already commenced remaining amortization period seven years impairment assets impairment losses calculating impairment losses group bases grouping assets smallest identifiable group assets generates largely independent cash inflows impairment losses recorded impairment losses consolidated statements income addition reversal impairment losses recorded income breakdown impairment losses reversals impairment losses segment follows millions yen fy fy january january december december pharmaceuticals nutraceuticals consumer products others corporate total pharmaceuticals impairment loss million pharmaceutical business recognized fy consists impairment losses property plant equipment million intangible assets million impairment loss property plant equipment million principally reduction carrying amount machinery vehicles tools furniture fixtures recoverable amount value use due decrease profitability impairment loss intangible assets million principally million impairment loss trademarks distribution rights others onzetra xsail million impairment loss inprocess research development centanafadine development code eb developed treatment attentiondeficit hyperactivity disorder adhd million impairment loss inprocess research development guadecitabine development code sgi developed treatment acute myeloid leukemia impairment loss onzetra xsail reduction full carrying amount due termination license agreement impairment loss centanafadine development code eb reduction carrying amount recoverable amount million value use initially assumed profitability longer expected calculation value use discount rate based pretax weighted average cost capital used impairment loss guadecitabine development code sgi reduction carrying amount recoverable amount million value use initially assumed profitability longer expected calculation value use discount rate based pretax weighted average cost capital used impairment loss reversal impairment loss pharmaceutical business recognized fy million million respectively impairment loss million consists impairment losses property plant equipment million goodwill million intangible assets million impairment losses property plant equipment million principally reduction carrying amount buildings structures machinery vehicles tools furniture fixtures recoverable amount value use due decrease profitability impairment losses intangible assets million principally reduction carrying amount inprocess research development trademarks distribution rights others recoverable amount value use due decrease profitability impairment test goodwill goodwill arising business combinations allocated cashgenerating units benefit business combination acquisition date breakdown carrying amount goodwill segment follows millions yen fy fy december december pharmaceuticals nutraceuticals consumer products others total carrying amount significant goodwill fy avanir pharmaceuticals inc pharmaceuticals million fy million astex pharmaceuticals inc pharmaceuticals million fy million visterra inc pharmaceuticals million fy million nutrition sant sas nutraceuticals million fy million group tests goodwill impairment fiscal period whenever indication impairment recoverable amount impairment test determined based value use value use reflects past experience external information calculated discounting estimated amount cash flows based business plan next five years approved management growth rate present value using discount rate based pretax weighted average cost capital cashgenerating unit growth rate determined view longterm average growth rate industry country cash generating unit belongs exceed longterm average growth rate market risk impairment may arise key assumptions used impairment test changed however value use adequately exceeds carrying amount cashgenerating unit considered unlikely value use falls carrying amount even key assumptions used impairment test change within reasonably predictable range impairment test intangible assets indefinite useful lives intangible assets indefinite useful lives included trademark rights fy principally brands held nutrition sant sas group nutraceuticals carrying amount million fy million brand tested impairment fiscal period whenever indication impairment using relieffromroyalty method excess earnings method value use reflects past experience external information determined using business plan next five years approved management discount rate equal pretax weighted average cost capital certain country risk foreign currency risk added necessary growth rate determined view longterm average growth rate industry country cashgenerating unit belongs exceed longterm average growth rate market value use adequately exceeds carrying amount case considered unlikely value use falls carrying amount even key assumptions used impairment test change within reasonably predictable range impairment test inprocess research development inprocess research development fy principally rights related research development avp carrying amount million fy million intangible assets yet available use inprocess research development tested impairment fiscal period whenever indication impairment recoverable amount impairment test determined based value use value use reflects past experience external information calculated discounting estimated amount cash flows based business plan next five years approved management growth rate present value using discount rate based pretax weighted average cost capital cashgenerating unit avp investments associates significant associates applicable individually insignificant associates carrying amount investments individually insignificant associates follows millions yen fy fy december december carrying amount investments associates financial information individually insignificant associates follows amounts adjustment groups ownership ratio millions yen fy fy january january december december profit year comprehensive income comprehensive income income taxes deferred taxes changes deferred tax assets deferred tax liabilities follows millions yen recognized balance balance changes recognized business january accounting profit others comprehensive combination december policies loss income inventories securities etc intangible assets postemployment benefits accrued expenses liabilities contract liabilities unused tax losses unused tax credits others total changes accounting policies due recording deferred tax assets million consolidated statement financial position beginning fy deferred tax liabilities decreased million deferred tax assets increased million compared application former accounting standards beginning fy result application ifrs millions yen recognized balance balance recognized january profit others comprehensive december loss income inventories securities etc intangible assets postemployment benefits accrued expenses liabilities contract liabilities unused tax losses unused tax credits others total recognizing deferred tax assets group takes account possibility part deductible temporary differences unused tax losses unused tax credits used future taxable profit assessment recoverability deferred tax assets reversal deferred tax liabilities expected future taxable profit tax planning taken account based level taxable profit past estimated future taxable profit period deferred tax assets deductible group considers probable deferred taxable assets recognized december recovered unrecognized deferred tax assets deductible temporary differences unused tax losses unused tax credits deferred tax asset recognized follows millions yen fy fy december december deductible temporary differences unused tax losses unused tax credits total deferred tax assets items recognized highly probable future taxable income necessary group utilize benefits arises deductible temporary differences expire current tax law expiration unused tax losses company subsidiaries follows millions yen fy fy december december st year nd year rd year th year th year onward total taxable temporary differences deferred tax liabilities recognized unrecognized deferred tax liabilities follows cases company control timing reversal temporary differences highly probable temporary differences reversed foreseeable period deferred tax liabilities associated temporary differences recognized millions yen fy fy december december temporary differences related investments subsidiaries associates deferred tax liabilities recognized company decided pay dividend foreseeable future income tax expenses effective tax rates fy fy japan respectively tax amount tax jurisdictions calculated using general tax rate jurisdiction breakdown current tax expenses deferred tax expenses follows millions yen fy fy january january december december current tax expenses current income taxes income taxes prior periods total current tax expenses deferred tax expenses origination reversal temporary differences etc changes unrecognized deferred tax assets total deferred tax expenses total income tax expenses reconciliation effective statutory tax rate actual tax rate fiscal year follows actual tax rate represents ratio income tax expenses profit taxes fy fy january january december december effective statutory tax rate special deduction research development expenses entertainment expenses deductible taxable income pharma fees deductible taxable income share profit associates changes unrecognized deferred tax assets difference tax rate applied subsidiaries others actual tax rate trade payables breakdown trade payables follows millions yen fy fy december december notes accounts payable trade accounts payable others total bonds borrowings breakdown bonds borrowings follows millions yen fy fy average december december interest rate year maturity secured current borrowings current portion noncurrent borrowings noncurrent borrowings excluding current portion unsecured current borrowings current portion noncurrent borrowings noncurrent borrowings excluding current portion bonds total bonds borrowings current bonds borrowings noncurrent average interest rate represents weighted average interest rate balance borrowings etc end year breakdown noncurrent borrowings repayment date fair values please refer note financial instruments summary terms conditions bonds issued follows fy fy interest date december december company name name rate collateral maturity issuance millions yen millions yen st otsuka holdings march march unsecured none co ltd bonds nd otsuka holdings march march unsecured none co ltd bonds rd otsuka holdings march march unsecured none co ltd bonds total figures brackets indicate amounts redeemed within one year financial liabilities breakdown financial liabilities follows millions yen fy fy december december financial liabilities financial liabilities measured amortized cost others financial liabilities measured fair value profit loss derivative liabilities contingent consideration total financial liabilities current financial liabilities noncurrent leases fy december comparative information presented fy based ias finance lease breakdown finance lease obligations follows millions yen fy december present value minimum minimum lease payments lease payments due within one year due one year five years due five years total deductionfuture finance costs present value minimum lease payments group policy conduct lease transaction group judged lease transaction merits comprehensively taking account aversion obsolescence risk reduction related expenses factors weighted average interest rate finance lease obligations fy contracts include renewal options contingent rent payable escalation clauses clauses specifying raise lease contract amount restriction imposed lease contracts restriction dividends additional borrowings additional leases maturity analysis lease liabilities group contractual undiscounted cash flows follows millions yen fy december due within one year due one year two years due two years three years due three years four years due four years five years due five years contractual cash flows balance lease liabilities end year recognized consolidated statement financial position current liabilities noncurrent liabilities operating leases breakdown groups future minimum lease payments payable noncancellable operating leases due date follows millions yen fy december due within one year due one year five years due five years total breakdown lease payments sublease payments operating lease contracts recognized expenses follows millions yen fy january december minimum lease payments contingent rent sublease payments received total group leases buildings vehicles assets lessee renewal options escalation clauses attached lease contracts addition restrictions restrictions additional borrowings additional leases imposed lease contracts fy december property plant equipment consists property plant equipment owned company rightofuse assets meet definition investment property rightofuse assets included property plant equipment consolidated statement financial position millions yen fy december property plant equipment owned company rightofuse assets total please refer note property plant equipment changes costs accumulated depreciation accumulated impairment losses property plant equipment carrying amounts rightofuse assets information leases group contracted lessee follows millions yen buildings machinery tools furniture carrying amount land total structures vehicles fixtures balance december adjustment due application ifrs balance january purchase depreciation expenses others balance december balance december carrying amount leased assets finance leases based ias buildings structures buildings structures principally consist leases plants office buildings warehouses estimated useful life years machinery vehicles machinery vehicles principally consist leases automobiles estimated useful life years tools furniture fixtures tools furniture fixtures principally consist leases vending machines equipment estimated useful life years land land principally consist leases land factories estimated useful life years lease liabilities maturity analysis lease liabilities group contractual undiscounted cash flows follows millions yen fy december due within one year due one year two years due two years three years due three years four years due four years five years due five years contractual cash flows balance lease liabilities end year recognized consolidated statement financial position current liabilities noncurrent liabilities amount recognized profit loss millions yen fy january december interest expense lease liabilities expense relating shortterm leases amount recognized statement cash flows millions yen fy january december total cash outflow leases liabilities breakdown liabilities follows millions yen fy fy december december liabilities accrued expenses deposits received employees bonuses others total total current liabilities current liabilities total noncurrent liabilities noncurrent liabilities provisions breakdown provisions follows millions yen fy fy december december provision asset retirement obligations total noncurrent liabilities breakdown changes provisions follows fy january december millions yen provision asset retirement provision loss litigation total obligations balance january increase year reversal discounts due passage time decrease year utilization decrease year reversal balance december fy january december millions yen provision asset retirement total obligations balance january increase year reversal discounts due passage time decrease year utilization decrease year reversal foreign currency translation differences others balance december details provisions follows provision asset retirement obligations group records provision asset retirement obligations estimated amount costs removal harmful substances related noncurrent assets estimated amount restoration costs rented offices others group obligations restore site original condition end lease contract group expects timing economic resources flow principally one year passed end fiscal year postemployment benefits group adopted defined benefit plans defined contribution plans postemployment benefit plans major domestic subsidiaries contributory funded defined benefit corporate pension plan lump sum retirement payments plan defined benefit plans defined contribution pension plans defined contribution plans certain foreign subsidiaries contributory funded unfunded defined benefit plans defined contribution plans combination among defined benefit plans major plan defined benefit plan japan accounts approximately total defined benefit obligations current fiscal year domestic subsidiaries abolished early retirement plans postemployment benefit pensions lumpsum payments accounting policy defined benefit plans please refer note significant accounting policies postemployment benefits defined benefit plans benefits defined benefit plans company major domestic subsidiaries amount retirement benefit payments calculated based service years salaries service period position factors period validity retiring employee equals certain period benefits paid lumpsum payment pension option employee upon retirement etc employees additional retirement benefits qualify benefits defined benefit plans may paid defined benefit corporate pension plans managed otsuka pharmaceuticals corporate pension fund directors pension fund pension plan management institution required laws regulations behave way gives utmost priority interest plan participants former participants assume responsibility managing plan assets prescribed policy although defined benefit retirement benefit plans exposed general investment risk interest rate risk others considered exposure risks significant amounts recognized consolidated statements financial position follows millions yen fy fy december december present value defined benefit obligations fair value plan assets funding position effect asset ceiling net amount defined benefit obligations plan assets amounts consolidated statements financial position net defined benefit liabilities net defined benefit assets noncurrent assets net defined benefit liabilitiesassets recognized consolidated statements financial position changes present value defined benefit obligations follows millions yen fy fy january january december december balance defined benefit obligations beginning year current service cost interest cost remeasurement difference assumption actual amount retirement benefit obligations actuarial gains losses arising changes demographic assumptions actuarial gains losses arising changes financial assumptions retirement benefits paid curtailmentsettlement foreign currency translation differences others balance defined benefit obligations end year changes fair value plan assets follows millions yen fy fy january january december december balance fair value plan assets beginning year interest income plan assets remeasurement return plan assets excluding interest income contributions employer retirement benefits paid curtailmentsettlement foreign currency translation differences others balance fair value plan assets end year group plans pay contributions million fy management policy plan assets fund management policy major plans group aims secure stable returns medium long term ensure payment defined benefit obligations future specifically assets managed setting target rate return asset mix investment asset within range acceptable risk defined annually maintaining mix group conducts review asset mix necessary taking account financial conditions defined benefit pension plans investment environment management asset implemented group seeks efficiency investment aspect continuous monitoring attention risk diversification associated asset managers fair value plan assets follows millions yen fy fy december december assets market assets without market assets market assets without market prices active markets prices active markets prices active markets prices active markets cash cash equivalents shares bonds others total companys investment policy defined benefit plans takes consideration various factors allowable limit deductible expenses tax laws funding status plan assets actuarial calculations changes effect asset ceiling follows millions yen fy fy january january december december balance effect asset ceiling beginning year interest income remeasurement effect limiting net defined benefit asset asset ceiling balance effect asset ceiling end year economic resource available future contributions reduced refunded consequently unrecognized surplus arisen pension plans group principal actuarial assumptions end reporting period follows fy fy december december discount rate following table represents sensitivity analysis significant actuarial assumptions sensitivity analysis shows impact increase decrease assumptions used actuarial calculation present value defined benefit obligations analysis based assumption variables constant analysis fy made using fundamentals fy millions yen fy fy january january december december increase discount rate decrease discount rate weighted average duration defined benefit obligations december years years respectively defined contribution plans amounts recognized expenses association defined contribution plans million fy million fy figures include amounts recognized expenses association public plans equity equity items share capital capital surplus changes number authorized shares total number issued shares balance share capital etc follows number authorized total number issued shares shares share capital capital surplus ordinary shares ordinary shares millions yen millions yen par value par value balance january shares shares changes year balance shares shares december changes year balance december shares shares treasury shares changes number balance treasury shares follows number shares amount shares millions yen balance january increase due request buyback shares less one share unit balance december increase due request buyback shares less one share unit decrease due disposal restricted stock compensation decrease due exercise stock options balance december company adopted stock option plan issues share acquisition rights pursuant companies act appropriates treasury shares grant shares line exercise rights stock option plan terminated due elapse applicable service period plan stock options exercised current fiscal year contractual terms conditions amount others plan provided note share based payments company adopted restricted stock compensation plan appropriates treasury shares grant shares plan contractual terms conditions amount others plan provided note sharebased payments capital surplus companies act japan hereinafter companies act least contribution share issue shall credited share capital remainder shall credited additional paidin capital included capital surplus addition companies act additional paidin capital transferred share capital upon approval shareholders meeting retained earnings companies act provides dividends shall appropriated additional paidin capital legal reserve aggregate amount additional paidin capital legal reserve equals share capital legal reserve may used eliminate reduce deficit may also reversed upon approval shareholders meeting details purpose components equity remeasurements defined benefit plans remeasurements defined benefit plans represent actuarial difference defined benefit obligation return plan assets excluding amount included interest income changes effect asset ceiling excluding amount included interest income actuarial difference represents adjustment based past experience defined benefit obligation difference actuarial assumptions beginning year actual results effect changes actuarial assumptions items recognized comprehensive income occurred immediately transferred components equity retained earnings ii financial assets measured fair value comprehensive income financial assets measured fair value comprehensive income represent valuation difference fair value financial assets measured fair value comprehensive income iii foreign currency translation reserve foreign currency translation reserve represents translation difference incurred consolidating financial statements foreign operations prepared using foreign currencies iv cash flow hedges group uses derivatives hedge risk fluctuation future cash flows cash flow hedges represent effective portion changes fair value derivative transactions designated cash flow hedges dividends dividends paid follows fy january december total amount dividends per share resolution dividends record date effective date yen millions yen meeting board directors held december march february meeting board directors held august june september fy january december total amount dividends per share resolution dividends record date effective date yen millions yen meeting board directors held december march february meeting board directors held august june september dividends whose effective date falls following fiscal year follows fy january december total amount dividends per share resolution dividends record date effective date yen millions yen meeting board directors held december march february fy january december total amount dividends per share resolution dividends record date effective date yen millions yen meeting board directors held december march february put options granted noncontrolling interests put options written shares foreign subsidiaries granted foreign subsidiaries owners noncontrolling interests recognized present value exercise price options financial liabilities amount deducted capital surplus initial recognition subsequent change recorded finance income finance costs remaining balance valuation techniques hierarchy recognized financial liabilities end fiscal year provided note financial instruments fair value financial instruments revenue disaggregation revenue group disaggregates revenue type goods services geographical area relationship disaggregated revenue reportable segments follows fy january december millions yen reportable segment pharma nutra consumer others total ceuticals ceuticals products type goods services sales products license royalty income others total geographical area japan north america others total revenue classified based location customers fy january december millions yen reportable segment pharma nutra consumer others total ceuticals ceuticals products type goods services sales products license royalty income others total geographical area japan north america others total revenue classified based location customers contract balance breakdown receivables contract liabilities contracts customers follows millions yen fy fy january december december receivables contracts customers notes accounts receivable trade allowance credit losses contract liabilities current liabilities contract liabilities noncurrent liabilities opening balance contract liabilities amount revenue recognized million fy million fy addition balance contract liabilities increased million fy million fy due receipt upfront payments achievement milestones license agreements development distribution rights others products developments factors amount revenue recognized performance obligations satisfied partially satisfied past period million fy million fy major revenue license royalty income timing satisfaction performance obligations contract liabilities mainly arise certain license agreements entered group third party development distribution rights others products development addition contract liabilities include advances received customers relation sale products total amount transaction price allocated remaining performance obligations timing revenue expected recognized follows millions yen fy fy january january december december due within one year due one year two years due two years three years due three years four years due five years total breakdown expenses nature major breakdown expenses included cost sales selling general administrative expenses research development expenses nature follows millions yen fy fy january january december december personnel expenses sales promotion expenses depreciation amortization expenses income breakdown income follows millions yen fy fy january january december december grant income rent received gain sales noncurrent assets change fair value contingent considerations gain fair value valuation reversal impairment losses others total income amount includes gain sales assets held sale fair value changes contingent considerations attributable time value recognized finance costs one attributable changes nontimevalue recognized either income expenses fair value changes contingent considerations recorded income relates acquisitions neurovance inc recor medical inc gain fair value valuation fy regard groups shareholding recor medical inc group held directly date control company obtained joint development commercializing agreement company includes recognition million remeasurement gain shareholding result remeasurement fair value date control company obtained million remeasurement gain joint development commercializing agreement expenses breakdown expenses follows millions yen fy fy january january december december loss sales noncurrent assets loss retirement noncurrent assets others total expenses finance income finance costs breakdown finance income finance costs follows millions yen fy fy january january december december finance income interest income financial assets measured amortized cost dividend income financial assets measured fair value comprehensive income gain fair value valuation financial assets liabilities measured fair value profit loss others total finance income finance costs interest expenses financial liabilities measured amortized cost lease liabilities loss fair value valuation financial assets liabilities measured fair value profit loss foreign exchange losses others total finance costs comprehensive income reclassification adjustments income taxes separate component comprehensive income follows millions yen fy fy january january december december components reclassified profit loss remeasurements defined benefit plans amount arising year income taxes income taxes remeasurements defined benefit plans financial assets measured fair value comprehensive income amount arising year income taxes income taxes financial assets measured fair value comprehensive income share comprehensive income associates amount arising year share comprehensive income associates subtotal components may reclassified profit loss foreign currency translation reserve amount arising year reclassification adjustments income taxes foreign currency translation reserve cash flow hedges amount arising year reclassification adjustments income taxes income taxes cash flow hedges share comprehensive income associates amount arising year reclassification adjustments share comprehensive income associates subtotal total comprehensive income earnings per share basis calculating basic earnings per share fy fy january january december december profit year attributable owners company millions yen profit year attributable ordinary equity holders company millions yen profit year used calculation basic earnings per share millions yen weighted average number ordinary shares thousands shares basic earnings per share yen basis calculating diluted earnings per share fy fy january january december december profit year used calculation basic earnings per share millions yen adjustments profit year millions yen profit year used calculation diluted earnings per share millions yen weighted average number ordinary shares thousands shares increase ordinary shares share acquisition rights thousands shares weighted average number diluted ordinary shares thousands shares diluted earnings per share yen sharebased payments group introduced restricted stock compensation plan directors company excluding outside directors certain directors subsidiaries fy aiming granting incentives achieve mediumterm management plan sustainably improve medium longterm performance corporate value company share value shareholders stock option plan introduced mediumterm incentive plan covering threeyear period fiscal year ended december fiscal year ended december terminated due elapse applicable period plan addition group adopted equitylinked compensation entitlements cashsettled sharebased payment plan officers employees certain consolidated subsidiaries group grants entitlements officers employees rank time grant makes payment cash taking account level achievement performance targets share price end period cycle cycle oneyear period cycle threeyear period restricted stock compensation plan details restricted stock compensation plan follows fy january december date grant may number shares granted shares fair value date grant settlement method equitysettled transfer restriction period may june persons granted directors company excluding outside directors certain directors subsidiaries hereinafter referred eligible directors company entered eligible director restricted stock allocation agreement contains provisions eligible directors shall transfer attach security interest make dispositions companys ordinary shares allotted hereinafter referred allotted shares company acquires allotted shares cost upon occurrence specified events provisions company shall remove transfer restriction allotted shares condition eligible director continued hold position director company director subsidiary eligible director director subsidiary transfer restriction period targets set company advance light consolidated revenue operating profit metrics achieved determined person eligible allotment retires due expiration term office reasonable cause time release transfer restriction number shares released transfer restriction reasonably adjusted necessary method measuring fair value calculated based closing price shares company first section tokyo stock exchange business day prior date resolution board directors stock options contractual terms stock options contractual terms stock options follows stock option directors company excluding outside directors directors persons granted subsidiaries concurrently serve directors company number stock options shares settlement method equitysettled date grant may target service period january december period share acquisition rights may march february exercised eligible person required continue rank director company subsidiaries right allotment date time exercising right provided however shall vesting conditions apply holders share acquisition rights retired left position director company subsidiaries due expiration term office request company companys board directors gives approval number stock options converted number shares ii changes number stock options exercise price changes number stock options exercise price follows stock option number stock options weighted average exercise price shares yen unexercised balance january granted exercised canceled unexercised balance december exercisable balance december granted exercised canceled unexercised balance december exercisable balance december number stock options converted number shares shares subject share acquisition rights granted represent maximum number exercisable rights number share acquisition rights ultimately become exercisable varies depending level achievement mediumterm management plan others therefore shares subject share acquisition rights ultimately become exercisable determined multiplying base number share acquisition rights determined position eligible person consideration content duties performed responsibilities fixed remuneration etc certain percentage according level achievement mediumterm management plan exercised fy weighted average share price stock options exercised time exercising right fy sharebased payment expenses breakdown sharebased payment expenses follows millions yen fy fy january january december december equitysettled cashsettled total carrying amount liabilities arising sharebased payment transactions million fy million fy financial instruments capital management groups basic policy capital management improve capital efficiency ensure financial soundness order achieve sustainable growth enhance corporate value medium long term group conducts monitoring financial indicators procedure capital management group monitors return equity attributable owners company capital efficiency ratio equity attributable owners company total assets financial soundness timely manner group subject material capital restrictions classification financial instruments breakdown financial assets financial liabilities category follows millions yen fy fy december december financial assets financial assets measured amortized cost cash cash equivalents trade receivables financial assets financial assets measured fair value profit loss financial assets financial assets measured fair value comprehensive income financial assets total financial assets financial liabilities financial liabilities measured amortized cost trade payables bonds borrowings financial liabilities financial liabilities measured fair value profit loss financial liabilities total financial liabilities financial risk management group exposed financial risks market risk credit risk liquidity risk course operating activities conducts risk management accordance certain policy mitigate financial risks group uses derivative transactions avoid foreign currency risks interest rate risks accordance policy carry speculative transactions market risk management groups activities mainly exposed risks changes economic circumstances financial market circumstances specifically risks changes financial market circumstances include foreign currency risk interest rate risk risk fluctuations equity instrument prices foreign currency risks foreign currency risk management group engages business globally fluctuations exchange rates us dollar euro principally affect operating results regard settlement receivables payables arising ongoing operating activities groups policy balance foreign exchange receipts payments much possible three major currencies namely us dollar euro yen specifically operating subsidiaries continuously engage export import transactions reduce frequency exchanging foreign currencies holding foreign currencies received export proceeds without exchanging local currency using directly payment imports order mitigate foreign currency risks ii foreign exchange sensitivity analysis group principally exposed foreign currency risks us dollar euro following table shows sensitivity analysis case yens value increases us dollar euro reporting period making calculations group assumed changes currencies used impact translation functional currencydenominated financial instruments assets liabilities profit expense foreign operations yen included based assumption variable factors balances interest rate constant millions yen fy fy january january december december usd impact profit taxes impact comprehensive income application tax effects eur impact profit taxes impact comprehensive income application tax effects figures parentheses represent negative effects profit loss equity group case yens value increases currency amounts show effects currency translation groups consolidated financial statements direct positive negative effects cash flows business management iii forward exchange contracts others regard management derivative transactions including forward exchange contracts group established management rules derivative transactions limits derivative transactions made purpose hedging risks group may enter forward exchange contracts agreements fix future cash flows related lending borrowing funds within group association receivables payables denominated foreign currencies determine amount dividends within group case group also manages contracts appropriately accordance internal rules breakdown forward exchange contracts others presented fair value financial instruments ii fair value derivatives interest rate risk interest rate risk management group exposed various interest rate risks business activities fluctuations interest rates associated borrowings especially affect operating results however effect interest rate fluctuations borrowing costs offset income arising assets affected interest rate fluctuations group monitors fluctuations interest rates arising assets liabilities manages interest rate risks refinancing means interest rates drastically fluctuate ii interest rate sensitivity analysis impact increase interest rates reporting period profit taxes group follows analysis calculation made multiplying balances financial instruments variable interest rates held group end reporting period assuming variables constant millions yen fy fy january january december december impact profit taxes risk fluctuations equity instrument prices management risk fluctuations equity instrument prices group exposed risk fluctuations share prices arising equity instruments shares group equity instruments held shortterm trading owns equity instruments smoothly execute business strategies group sell investments actively regard equity instruments group regularly assesses monitors fair value financial conditions issuers ii price sensitivity analysis equity instruments shares held group following table shows impact decrease share price comprehensive income application tax effects group assuming variables constant millions yen fy fy january january december december impact comprehensive income application tax effects iii financial assets measured fair value comprehensive income fair value financial assets measured fair value comprehensive income dividend income follows millions yen fy fy january january december december fair value dividend income fair value dividend income listed unlisted total fair values major financial assets follows group classifies investments held purpose participating management investees encouraging alliance enterprises reinforcing sales foundations financial assets measured fair value comprehensive income fy december millions yen name amount listed daiichi sankyo company limited eiken chemical co ltd awa bank ltd bml inc donga st co ltd others unlisted pharmaceuticals electrical equipment food others total names major unlisted shares nichia corporation electrical equipment proteus digital health inc pharmaceuticals somalogic inc pharmaceuticals fy december millions yen name amount listed daiichi sankyo company limited eiken chemical co ltd awa bank ltd bml inc donga st co ltd others unlisted electrical equipment pharmaceuticals food others total names major unlisted shares nichia corporation electrical equipment somalogic inc pharmaceuticals pact pharma inc pharmaceuticals iv derecognition group sells derecognizes financial assets measured fair value comprehensive income purpose reviewing portfolio regularly managing risk assets others fair value time sale cumulative gains losses pretax follows millions yen fy fy january january december december fair value time sale cumulative gains losses fair value time sale cumulative gains losses item transferred comprehensive income retained earnings time sale amounts net tax transferred fy fy million cumulative gains million cumulative losses respectively fy fy dividend income financial assets measured fair value comprehensive income sold derecognized million million respectively offsetting financial assets financial liabilities december december significant financial instruments offset consolidated statements financial position among financial assets financial liabilities recognized counterparty also significant financial instruments enforceable master netting arrangements similar contracts offset meet certain criteria offsetting financial assets financial liabilities credit risk management credit risks risks result financial losses incurred group customer goes default contractual obligations group sales department accounting finance department monitor status business partners terms trade receivables etc regularly manage due dates balances business partner working early identify mitigate concerns collections due deterioration business partners financial position factors full partial collection trade receivables etc considered impossible extremely difficult deemed default respect shares securities investment securities financial situation issuers assessed regularly accordance management rules group company respect public corporate bonds credit risk insignificant group invests solely highly rated bonds group recognizes extremely insignificant credit risk use derivatives since deals financial institutions high credit ratings mitigate credit risk group credit risk overly concentrated specific counterparty group counterparty belongs allowance credit losses financial assets impaired group reduce impairment directly carrying amount accounts impairment allowance credit losses account changes allowance credit losses follows fy january december millions yen lifetime expected credit losses financial assets financial assets total credit risk increased always measured significantly since initial amount equal lifetime recognition expected credit losses balance january increase year decrease year utilization decrease year reversal others balance december fy january december millions yen lifetime expected credit losses financial assets financial assets total credit risk increased always measured significantly since initial amount equal lifetime recognition expected credit losses balance january increase year decrease year utilization decrease year reversal others balance december exposure credit risk financial assets carrying amounts impairment presented consolidated statements financial position represent groups maximum exposure credit risk financial assets liquidity risk management group manages liquidity risk accounting finance department prepares updates cash flow management plan maintaining constant level liquidity temporary shortage cash due payment dividends bonuses items covered loan bank financial institution balance financial liabilities liability guarantee including derivative financial instruments maturity follows details lease liabilities provided note leases millions yen due due due due due fy carrying contractual due within one year two years three years four years five december amount cash flows one year two five years years three years four years years nonderivative financial liabilities trade payables borrowings contingent consideration others total derivative financial liabilities forward exchange contracts others interest rate swaps currency swaps total millions yen due due due due due fy carrying contractual due within one year two years three years four years five december amount cash flows one year two five years years three years four years years nonderivative financial liabilities trade payables borrowings bonds payable contingent consideration others total derivative financial liabilities forward exchange contracts others interest rate swaps currency swaps total fair value financial instruments details fair values financial instruments provided note significant accounting policies financial instruments fair value hierarchy fair value hierarchy classifies fair values follows level fair value measured based quoted prices active markets level fair value calculated directly indirectly using observable price level prices level fair value calculated using valuation techniques including unobservable inputs transfers fair value hierarchy levels recognized date event condition prompting transfer occurred financial instruments measured amortized cost millions yen fair value fy carrying amount december level level level total financial assets securities total financial liabilities borrowings total millions yen fair value fy carrying amount december level level level total financial assets securities total financial liabilities borrowings bonds total calculation method fair values follows securities fair value securities determined based quoted price securities exchange borrowings fair value borrowings floating interest rates reflects market interest rates short term carrying amount approximates fair value fair value borrowings fixed interest rates determined method future cash flows discounted using interest rate approximates funds borrowed terms conditions remaining borrowing period bonds fair value bonds determined based observable price market ii fair value derivatives millions yen fy derivatives designated cash flow hedges total december hedges forward exchange contracts others interest rate swaps currency swaps total millions yen fy derivatives designated cash flow hedges total december hedges forward exchange contracts others interest rate swaps currency swaps total calculation method fair values follows forward exchange contracts others fair value forward exchange contracts others calculated based market price forward exchange contracts others entered similar terms conditions interest rate swaps interest rate swaps used purpose reducing interest borne borrowings fair value calculated based value presented creditor financial institutions currency swaps currency swaps used purpose reducing foreign currency risks currencies borrowings fair value calculated based value presented creditor financial institutions iii financial instruments measured fair value millions yen fy level level level total december financial assets financial assets measured fair value comprehensive income equity instruments financial assets measured fair value profit loss equity instruments derivatives total financial liabilities financial liabilities measured fair value profit loss derivatives contingent consideration total millions yen fy level level level total december financial assets financial assets measured fair value comprehensive income equity instruments financial assets measured fair value profit loss equity instruments total financial liabilities financial liabilities measured fair value profit loss derivatives contingent consideration total fy fy significant transfer level transfer level level due listing shares held please refer v reconciliation financial instruments classified level opening balances closing balances transfer iv valuation techniques inputs financial instruments classified level level valuation techniques inputs equity instruments fair values equity instruments measured using valuation technique appropriate characteristics instrument comparable company analysis method option pricing method measurement input information including stock price index comparable companies discount rate according risk instrument price conversion preference shares held group ordinary shares taken account derivatives information provided note financial instruments fair value financial instruments ii fair value derivatives contingent consideration contingent considerations classified level liabilities recognized result recognizing part considerations contingent considerations acquisition shares neurovance inc shares recor medical inc past valuation techniques inputs fair value provided note business combinations b valuation processes fair values level financial instruments measured based internal regulations group adopted appropriate valuation techniques inputs reflect risks characteristics nature financial instruments subject valuation v reconciliation financial instruments classified level opening balances closing balances fair value measurement end year fy millions yen january december financial assets financial liabilities balance beginning year gains losses recorded profit loss recorded comprehensive income purchase issuance increase business combinations sales settlements transfer level due listing others balance end year unrealized gains losses included profit loss assets liabilities held end year fair value measurement end year fy millions yen january december financial assets financial liabilities balance beginning year gains losses recorded profit loss recorded comprehensive income purchase issuance sales settlements transfer level due listing transfer level due delisting others balance end year unrealized gains losses included profit loss assets liabilities held end year gains losses included profit loss relate financial assets financial liabilities measured fair value profit loss reporting date gains losses included income finance income finance costs consolidated statements income gains losses included comprehensive income mainly relate financial assets measured fair value comprehensive income reporting date gains losses included financial assets measured fair value comprehensive income foreign currency translation reserve consolidated statements comprehensive income transfer financial assets group discounts certain notes receivable banks due date note endorses certain notes suppliers etc even notes discounted banks endorsed suppliers etc group required purchase notes back bank discount made supplier etc note honored therefore discounted notes endorsed notes continue recognized notes receivable due date note included presented trade receivables amounts received due endorsement discount presented financial liabilities financial liabilities discounted notes etc related discounted notes endorsed notes etc december december follows millions yen fy fy december december financial liabilities discounted notes etc hedge accounting group utilizes derivatives forward exchange contracts others hedge foreign currency risk associated forecast transactions denominated foreign currencies effect hedge accounting consolidated statements financial position follows hedging instrument fy december millions yen line item carrying amount change fair statement notional hedging instrument value using financial position types risk hedging amount calculation hedges classification instrument hedging ineffective hedging instrument assets liabilities portion instrument hedge recorded forward foreign cash flow exchange financial currency hedges contracts assets current risks others fy december millions yen line item carrying amount change fair statement notional hedging instrument value using financial position types risk hedging amount calculation hedges classification instrument hedging ineffective hedging instrument assets liabilities portion instrument hedge recorded forward foreign cash flow exchange financial currency hedges contracts liabilities current risks others hedged items fy december millions yen change fair value using calculation reserve cash flow types hedges risk classification ineffective portion hedges hedge foreign currency cash flow hedges risks fy december millions yen change fair value using calculation reserve cash flow types hedges risk classification ineffective portion hedges hedge foreign currency cash flow hedges risks amounts affected consolidated statements comprehensive income association cash flow hedges fy december millions yen line item gains losses amount profit loss hedges ineffective transferred line item risk recognized portion reserve profit loss types hedges includes classification recognized cash flow affected ineffective comprehensive profit loss hedges transfer portion income profit loss hedge foreign cash flow hedges currency cost sales risks fy december millions yen line item gains losses amount profit loss hedges ineffective transferred line item risk recognized portion reserve profit loss types hedges includes classification recognized cash flow affected ineffective comprehensive profit loss hedges transfer portion income profit loss hedge foreign cash flow hedges currency cost sales risks figure represents amount tax effect adjustments subsidiaries associates significant subsidiaries associates company presented overview company overview affiliated entities japanese related parties related party transactions outstanding balances transactions company consolidated subsidiaries companys related parties consolidated subsidiaries eliminated consolidation disclosed notes significant transaction volume balances payables receivables group related parties remuneration key management personnel remuneration key management personnel group follows millions yen fy fy january january december december fixed remuneration bonuses postemployment benefits sharebased payment total remuneration key management personnel business combinations significant business combinations fy january december acquisition recor medical inc company exercised acquisition option acquire remaining shares recor medical inc previously companys associate company june japan time made recor medical inc wholly owned subsidiary hereinafter referred acquisition recor medical inc manufactures develops medical devices united states overview business combination name company acquired nature business name company acquired recor medical inc nature business manufacture development medical devices ultrasound renal denervation devices b primary reasons business combination group minority interest recor medical inc since obtained exclusive development sales rights ultrasound renal denervation therapeutic devices asia since two parties developed good working relationship jointly developing device conducting require test japan south korea recor medical incs clinical trial radiancehtn solo trial showed positive result june obtained permission implement next clinical trial radiance ii food drug administration fda us group exercised acquisition option c acquisition date june acquisition background percentage voting equity interests acquired acquisition group held voting equity interests result exercising acquisition option group acquired remaining shares converted existing convertible loans otsuka medical devices co ltd held recor medical inc become owned subsidiary group ii fair values consideration transferred assets acquired liabilities assumed acquisition date millions yen amount fair value consideration transferred cash contingent consideration fair value existing shareholding others millions yen amount fair value assets acquired liabilities assumed current assets noncurrent assets current liabilities noncurrent liabilities fair value assets acquired liabilities assumed goodwill total amount others fair value consideration transferred includes fair values acquisition option existing convertible loans contractual rights basis joint development commercializing agreement group recor medical inc hereinafter referred codevelopment commercializing agreement fair value codevelopment commercializing agreement based estimated future cash flows arising contract group remeasured existing shareholding acquisition option convertible loans codevelopment commercializing agreement fair value date acquisition group recognizes million remeasurement gain shareholding million remeasurement gain acquisition option million remeasurement gain convertible loans million remeasurement gain codevelopment commercializing agreement remeasurement gains shareholding codevelopment commercializing agreement included income remeasurement gains acquisition option convertible loans included finance income consolidated statement income acquisitionrelated costs million included selling general administrative expenses consolidated statement income acquired trade receivables contractual cash flow expected collected major components goodwill synergies existing businesses expected generated acquisition excess earnings power regard goodwill amount expected deductible tax purposes noncurrent assets major component allocated intangible assets inprocess research development million noncurrent liabilities deferred tax liabilities recognized business combination million iii effect operating results group amounts revenue profit loss recor medical inc since acquisition date included groups consolidated statement income insignificant furthermore information revenue profit loss assumption acquisition date january socalled proforma information disclosed effect insignificant acquisition visterra inc july otsuka pharmaceutical co ltd otsuka consolidated subsidiary company entered agreement acquire shares visterra inc visterra engaged research development pharmaceutical products united states acquisition company set otsuka america inc otsuka america consolidated subsidiary company acquisition completed august overview business combination name company acquired nature business name company acquired visterra inc nature business research development pharmaceutical products b primary reasons business combination visterra unique antibody platform technologies hierotope platform enable computer estimations threedimensional structures portion protein deemed essential function simulations structure combination numerous partial structures antibodies detection optimal antibody structures design antibody drugs technologies may make possible develop antibody drugs many biological materials previously considered difficult address visterra already created several clinical development products antibody technologies also multiple programs move clinical development soon among clinical trial launched vis aimed treatment iga nephropathy effective therapeutic approach disease currently approved medication otsuka promote drug development newly acquiring base antibody drug discovery addition existing base smallmolecule drug discovery acquisition c acquisition date august acquisition background percentage voting equity interests acquired acquisition company set otsuka america acquired outstanding voting shares visterra exchange cash ii fair values consideration transferred assets acquired liabilities assumed acquisition date millions yen amount fair value consideration transferred cash fair value assets acquired liabilities assumed current assets noncurrent assets current liabilities noncurrent liabilities fair value assets acquired liabilities assumed goodwill total acquisitionrelated costs million included selling general administrative expenses consolidated statement income total amount trade receivables million none expected uncollectible major components goodwill synergies existing businesses expected generated acquisition excess earnings power regard goodwill amount expected deductible tax purposes noncurrent assets major component allocated intangible assets inprocess research development million intangible assets million noncurrent liabilities deferred tax liabilities recognized business combination million iii effect operating results group amounts revenue profit loss visterra since acquisition date included groups consolidated statement income insignificant furthermore information revenue profit loss assumption acquisition date january socalled pro forma information disclosed effect insignificant fy january december fy significant business combinations contingent consideration contingent considerations arose business combination neurovance inc recor medical inc contingent considerations acquisition neurovance inc consist milestones paid based progress development centanafadine compound development treatment adhd obtained group acquired neurovance inc march ones paid based revenue launch centanafadine maximum potential amounts milestones usd million usd million respectively contingent considerations acquisition recor medical inc milestones paid based progress development ultrasound renal denervation device obtained group acquisition june maximum potential amount milestones usd million fair value contingent considerations estimated based probabilityweighted present value potential amount paid counterparty level contingent considerations fair value hierarchy classified level fair value changes contingent considerations attributable time value recognized finance costs one attributable changes nontimevalue recognized either income expenses details fair value hierarchy provided note financial instruments changes fair value contingent considerations follows millions yen amount balance january business combination changes fair value foreign currency translation adjustment balance december changes fair value foreign currency translation adjustment balance december cash flow information fy january december payments acquisition subsidiaries provided note business combinations group acquired shares recor medical inc visterra inc one company following represents amounts assets liabilities purchase consideration transferred acquisition date millions yen fy january december current assets noncurrent assets goodwill current liabilities noncurrent liabilities total consideration transferred acquisition subsidiaries less amount contingent considerations included consideration transferred less amount noncash transactions included consideration transferred less cash cash equivalents held acquired companies time acquisition foreign currency translation others cash cash equivalents spent gain control fy january december applicable reconciliation liabilities arising financing activities reconciliation liabilities classified cash flows financing activities follows fy january december millions yen changes due noncash transactions balance balance january cash flow business exchange changes december combination leases transfer rate fair value others fluctuations current liabilities bonds borrowings lease liabilities financial liabilities total noncurrent liabilities bonds borrowings lease liabilities financial liabilities total fy january december millions yen changes due noncash transactions balance adjustment balance balance due cash exchange december application january flow december leases transfer rate ifrs fluctuations current liabilities bonds borrowings lease liabilities financial liabilities total noncurrent liabilities bonds borrowings lease liabilities total commitments commitments related expenditures reporting date follows millions yen fy fy december december acquisition property plant equipment acquisition intangible assets commitments related acquisition intangible assets group entered license agreements etc development distribution rights others products development finished products third parties group may pay certain amount money milestones related development sales targets specified agreements achieved represents maximum amount paid milestones achieved may different amount actually paid risk adjustment discount made amount contingent liabilities amount liability guarantee group provided guarantee borrowings associates financial institutions follows millions yen fy fy december december outstanding guarantees subsequent events applicable others quarterly information fy cumulative period first quarter second quarter third quarter full year revenue millions yen profit taxes millions yen profit attributable owners millions yen company basic earnings per share yen accounting period first quarter second quarter third quarter fourth quarter basic earnings per share yen ii litigation etc applicable iii events reporting date applicable